These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3780825)

  • 1. Oral bioavailability of high-dose metoclopramide.
    Taylor WB; Bateman DN
    Eur J Clin Pharmacol; 1986; 31(1):41-4. PubMed ID: 3780825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and efficacy of high-dose metoclopramide given by continuous infusion for the control of cytotoxic drug-induced vomiting.
    Taylor WB; Proctor SJ; Bateman DN
    Br J Clin Pharmacol; 1984 Nov; 18(5):679-84. PubMed ID: 6508977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics of metoclopramide in man with observations in the dog.
    Bateman DN; Kahn C; Davies DS
    Br J Clin Pharmacol; 1980 Apr; 9(4):371-7. PubMed ID: 7378253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiemetic effect and pharmacokinetics of high dose metoclopramide in cancer patients treated with cisplatin-containing chemotherapy regimens.
    Havsteen H; Nielsen H; Kjaer M
    Eur J Clin Pharmacol; 1986; 31(1):33-40. PubMed ID: 3780824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose metoclopramide by infusion: a double-blind study of plasma concentration-effect relationships in patients receiving cancer chemotherapy.
    Taylor WB; Simpson JM; Bateman DN
    Eur J Clin Pharmacol; 1987; 33(2):161-5. PubMed ID: 3319642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the antiemetic effect of high-dose intravenous metoclopramide and high-dose intravenous haloperidol in a randomized double-blind crossover study.
    Grunberg SM; Gala KV; Lampenfeld M; Jamin D; Johnson K; Cariffe P; Strych D; Krailo M
    J Clin Oncol; 1984 Jul; 2(7):782-7. PubMed ID: 6539812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of high-dose metoclopramide in cancer patients.
    McGovern EM; Grevel J; Bryson SM
    Clin Pharmacokinet; 1986; 11(6):415-24. PubMed ID: 3542335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacokinetics of single doses of metoclopramide in renal failure.
    Bateman DN; Gokal R; Dodd TR; Blain PG
    Eur J Clin Pharmacol; 1981; 19(6):437-41. PubMed ID: 7250177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of ondansetron with metoclopramide in prevention of acute emesis associated with low dose & high dose cisplatin chemotherapy.
    Bhatia A; Tripathi KD; Sharma M
    Indian J Med Res; 2003 Jul; 118():33-41. PubMed ID: 14748464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [High dose metoclopramide during cancer chemotherapy. Phase II study in 80 consecutive patients].
    Bui NB; Marit G; Albin H; Durand M; Mauriac L; Hoerni B
    Bull Cancer; 1982; 69(4):330-5. PubMed ID: 7150789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metoclopramide kinetics at high-dose infusion rates for prevention of cisplatin-induced emesis.
    Saller R; Hellenbrecht D; Briemann L; Hellstern A; Hess H; Mitrou P; Hodgson M; Achtert G; Brockmann P; Hausleiter HJ
    Clin Pharmacol Ther; 1985 Jan; 37(1):43-7. PubMed ID: 4038385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective control of chemotherapy-induced nausea and vomiting with oral prednisone and metoclopramide.
    Senn HJ; Glaus A; Bachmann-Mettler I
    J Clin Oncol; 1984 Apr; 2(4):320-2. PubMed ID: 6538593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic studies of high-dose metoclopramide with and without forced diuresis.
    Ell C; Braun J; König HJ; Domschke S; Domschke W
    Klin Wochenschr; 1985 Jun; 63(12):572-4. PubMed ID: 3928960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single-blind comparison of intravenous ondansetron, a selective serotonin antagonist, with intravenous metoclopramide in the prevention of nausea and vomiting associated with high-dose cisplatin chemotherapy.
    Hainsworth J; Harvey W; Pendergrass K; Kasimis B; Oblon D; Monaghan G; Gandara D; Hesketh P; Khojasteh A; Harker G
    J Clin Oncol; 1991 May; 9(5):721-8. PubMed ID: 1826739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-dose pharmacokinetics of metoclopramide.
    Ross-Lee LM; Eadie MJ; Hooper WD; Bochner F
    Eur J Clin Pharmacol; 1981; 20(6):465-71. PubMed ID: 7286058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacokinetics of metoclopramide.
    Bateman DN
    Clin Pharmacokinet; 1983; 8(6):523-9. PubMed ID: 6360466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative study on the tolerance and efficacy of high doses of metoclopramide and clebopride in vomiting induced by cisplatin].
    Martín M; Díaz-Rubio E
    Med Clin (Barc); 1989 Jun; 93(2):50-3. PubMed ID: 2755259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absolute bioavailability of metoclopramide given orally or by enema in patients with normal liver function or with cirrhosis of the liver.
    Hellstern A; Hellenbrecht D; Saller R; Gatzen M; Manus B; Achtert G; Brockmann P; Hausleiter HJ; Leuschner U
    Arzneimittelforschung; 1987 Jun; 37(6):733-6. PubMed ID: 3663273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High efficacy of a single oral dose of ondansetron 8 mg versus a metoclopramide regimen in the prevention of acute emesis induced by fluorouracil, doxorubicin and cyclophosphamide (FAC) chemotherapy for breast cancer.
    Bosnjak SM; Nesković-Konstantinović ZB; Radulović SS; Susnjar S; Mitrovi LB
    J Chemother; 2000 Oct; 12(5):446-53. PubMed ID: 11128567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous i.v. infusion versus multiple bolus doses of metoclopramide for prevention of cisplatin-induced emesis.
    Agostinucci WA; Gannon RH; Golub GR; Martin RS; Schauer PK; Dinonno EB
    Clin Pharm; 1988 Jun; 7(6):454-7. PubMed ID: 3402181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.